ASPC 2026 Congress to Debate Controversial Guidelines, Expand Training Pipeline
Event summary
- ASPC's 2026 Congress (July 31-Aug 2) features six headline debates challenging 2026 CVD prevention guidelines
- Pre-Conference Training Academy expands to 50 clinicians-in-training, up from inaugural year
- Joint session with National Lipid Association to cover lipid management controversies
- Honorary Fellow Award to Katherine Wilemon, CEO of Family Heart Foundation
The big picture
The 2026 Congress highlights ASPC's strategic focus on both thought leadership in guideline interpretation and workforce development. The organization is positioning itself as the central forum for resolving emerging controversies in CVD prevention while systematically expanding its influence over the next generation of practitioners. The joint session with NLA suggests growing recognition of the need for coordinated education across cardiovascular subspecialties.
What we're watching
- Guideline Controversy
- Whether ASPC's platforming of guideline debates will accelerate or delay consensus on 2026 CVD prevention standards
- Training Pipeline
- The pace at which the expanded Training Academy can address preventive cardiology workforce shortages
- Cross-Society Collaboration
- How the NLA joint session may influence future ASPC partnerships in lipid management education
